GLUE
#2310
Monte Rosa Therapeutics, Inc. - Common Stock
14.3 1 USD
+0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.65%
Variación mensual
-14.00%
Variación en los últimos 6 meses
-18.97%
Cambio anual
+26.64%
Cierres anteriores
13.9 4
Open
14.3 1
Mínimo
14.3 1
Máximo
14.3 1
Volumen
76
Financials
- Market Capitalization 1.22 B
- Employee 173
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-13.75
Relación precio/flujo de caja
75.87
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2306 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 13.96 USD | -1.06% | -4.64% | +21.08% | +293.24% | 1.23 B USD | ||
| 2307 |  ALMS Alumis Inc. - Common Stock | 9.47 USD | -56.58% | -60.38% | -65.80% | +109.98% | 1.23 B USD | ||
| 2324 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.27 USD | +1.64% | -1.92% | +8.35% | +151.68% | 1.20 B USD | ||
| 2352 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.89 USD | +3.68% | +2.89% | +23.95% | -16.75% | 1.15 B USD |